Benzinga Pro offers a real-time newsfeed as headlines break on earnings releases, analyst ratings, rumors, the biggest movers, and many more actionable alerts.

Find Stocks Tailored to Your Trading Interests

benzingaproreview-1-1280x720

acf/call-to-action

<a href="https://share.hsforms.com/1kQ-soZmmTRqplsRXp5Zfpw1npzh">Claim Exclusive Offers</a>

Compare Investing Brokers (USE THIS ONE)

acf/widget-container

acf/compare-products

IBKR Stocks

Plus500 Yield

public.com

Robinhood

TradeZero

Compare Crypto Brokers Homepage

Gemini Crypto

Plus500 Crypto

Kraken

Binance NON US

Compare Brokers Table – Benzinga.com

Afya

Vasta Platform

Vasta Platform Limited - Class A Ordinary Shares

Auna

Vitru

Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends.

Mauricio Cepeda's

Lennar Corp (LEN)

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.



<ul>
<li>Keefe, Bruyette &amp; Woods analyst Jade Rahmani downgraded the rating for Lennar Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEN#NYSE">LEN</a>) from Outperform to Market Perform and lowered the price target from $152 to $141. Lennar shares closed at $125.22 on Monday. <a href="https://www.benzinga.com/quote/len/analyst-ratings">See how other analysts view this stock</a>.</li>



<li>Morgan Stanley analyst Mauricio Cepeda downgraded Afya Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFYA#NASDAQ">AFYA</a>) from Equal-Weight to Underweight and cut the price target from $19 to $17. Afya shares closed at $16.97 on Monday. <a href="https://www.benzinga.com/quote/afya/analyst-ratings">See how other analysts view this stock</a>.</li>



<li>HC Wainwright &amp; Co. analyst Joseph Pantginis downgraded the rating for Checkpoint Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CKPT#NASDAQ">CKPT</a>) from Buy to Neutral and announced a $4.1 price target. Checkpoint Therapeutics shares closed at $3.98 on Monday. <a href="https://www.benzinga.com/quote/ckpt/analyst-ratings">See how other analysts view this stock</a>.</li>



<li>Jefferies analyst Laurence Alexander downgraded the rating for Green Plains Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GPRE#NASDAQ">GPRE</a>) from Buy to Hold and lowered the price target from $14 to $6. Green Plains shares closed at $5.48 on Monday. <a href="https://www.benzinga.com/quote/GPRE/analyst-ratings">See how other analysts view this stock</a>.</li>



<li>Leerink Partners analyst Daina Graybosch downgraded 2seventy bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSVT#NASDAQ">TSVT</a>) from Outperform to Market Perform and lowered the price target from $9 to $5. 2seventy bio shares closed at $2.80 on Monday. <a href="https://www.benzinga.com/quote/TSVT/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>



Considering buying LEN stock? Here&#8217;s what analysts think: 



<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="596" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/11091355/image-67-1024x596.png" alt="" class="wp-image-818780" style="width:624px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/11091355/image-67-1024x596.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/11091355/image-67-300x175.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/11091355/image-67-768x447.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/11091355/image-67.png 1138w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>



Read This Next: 



<ul>
<li><a href="https://www.benzinga.com/25/03/44218016/top-3-financial-stocks-that-may-fall-off-a-cliff-in-march">Top 3 Financial Stocks That May Fall Off A Cliff In March</a></li>
</ul>

News

Downgrades

Analyst Ratings

Trading Ideas

AFYA

CKPT

GPRE

TSVT

This Lennar Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Analyst Ratings Newsletter

Don't Miss Your Daily Analyst Rating Email!!!

acf/beehiiv-email-capture

acf/raptive-ad-placement

Investing Channel Sidebar Top

acf/investing-channel-block

acf/news-feed

Analyst Ratings Sidebar

Application error: a client-side exception has occurred (see the browser console for more information).